AIFU
AIFU's revenue fell 58.2% to CN¥557 million in fiscal 2025. Its operating margin was −7.0%, up from −33.6% a year earlier. Free cash flow was −CN¥20 million, against CN¥134 million a year earlier. The diluted share count fell 99.6%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity.
What AIFU does
AIFU sells insurance in mainland China as a go-between: it distributes policies that insurance companies write, rather than taking on the risk itself. Most of its customers are individuals and families, and most are under 50. It sells life and health insurance, such as critical illness, annuity, whole life and term life policies, and through a brokerage firm it also arranges property, cargo and liability cover for businesses. Its agents sell and service policies through its own apps, which include tools built on artificial intelligence.
It reports a single segment, insurance agency, and earns commissions from the insurers whose products it sells. Life and health insurance made up 92.6% of its net revenues in 2025, and other insurance 7.4%. In January 2025 it sold its claims adjusting business. It competes with other insurance intermediaries, with insurers' own sales forces, with companies that sell insurance online, and with banks and post offices that sell it on the side.
As of March 31, 2026, it worked with 42,170 registered independent sales agents, most of whom are not its employees, from 313 sales outlets in 23 provinces, and with 67 insurance companies. Founded in 1998, it says it has served about 19.8 million individual customers.
Its biggest risks, as it describes them
- Insurance companies could end or change its distribution contracts, which usually last a year, or cut the commissions they pay it.
- Failing to attract and keep productive sales agents, most of whom are independent rather than employees.
- Chinese regulators have tightened rules on life insurance pricing and commissions, which has already reduced its revenue.
- Its reliance on outside providers to run its digital platforms since it sold its own online insurance business.
- After selling businesses in 2025, it depends more heavily on its core insurance agency work and new plans to grow it.
Income statement
From fiscal 2016 to 2024, earnings per share grew 15.8% a year and net income 13.3% a year, as new shares raised the share count by 121% and diluted each share's earnings. AIFU then lost money in fiscal 2025.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 1,422 | 899 | 1,450 | 722 | — |
| Debt incl. finance leases | — | — | — | — | — |
| Net debt (negative means net cash) | — | — | — | — | — |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | — | — | — | — | — |
| Interest coverage | — | — | 20.2x | −134.4x | −10.3x |
| Current ratio | 2.5x | 2.4x | 2.3x | 2.5x | 1.2x |
| Quick ratio | 2.5x | 2.4x | 2.3x | 2.5x | 1.2x |
Cash flow
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | 2.5% | −41.7% | −61.7% |
| Altman Z'' | 4.98 | 4.43 | 0.19 |
| Accruals ratio | 5.0% | 7.6% | −79.6% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Fail |
| Cash from operations is positive | Pass | Pass | Fail |
| Return on assets rose | Pass | Pass | Fail |
| Cash from operations exceeds net income | Fail | Fail | Pass |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Fail | Pass | Pass |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | Pass | Fail | Fail |
| F-score | — | — | — |
Compare
Put AIFU side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| AIFU | FY25 | −58.2% | −7.0% | −3.5% | — | — | — | |
| eHealth | FY25 | 4.1% | 12.0% | −5.0% | 7.5% | 0.5x | 4 | Compare |
| Ethos Technologies | FY25 | 52.0% | 18.8% | 9.0% | — | — | — | Compare |
| Goosehead Insurance | FY25 | 16.1% | 20.4% | 23.6% | 75.5% | 3.0x | 5 | Compare |
| XChange TEC.INC | FY25 | 26.7% | −197.2% | — | — | — | — | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 4,083 | 4,088 | 3,471 | 3,706 | 3,268 | 3,271 | 2,782 | 2,760 | 1,332 | 557 |
| Revenue growth | 66.0% | 0.1% | −15.1% | 6.8% | −11.8% | 0.1% | −15.0% | −0.8% | −51.8% | −58.2% |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | −8 | 273 | 426 | 469 | 302 | 302 | 169 | 176 | −447 | −39 |
| Net income | 168 | 452 | 617 | 193 | 268 | 251 | 100 | 280 | 455 | −2,275 |
| Diluted EPS (CNY) | 0.13 | 0.36 | 0.49 | 0.17 | 0.25 | 0.23 | 0.09 | 0.26 | 0.42 | −224.87 |
| Diluted shares (millions) | 1,209 | 1,261 | 1,241 | 1,093 | 1,074 | 1,074 | 1,074 | 2,692 | 2,676 | 10 |
| Cash flow | ||||||||||
| Cash from operations | 88 | 152 | 524 | 178 | 402 | 126 | 138 | 102 | 143 | −16 |
| Capital expenditure | 12 | 21 | 23 | 20 | 15 | 31 | 78 | 13 | 8 | 3 |
| Free cash flow | 76 | 131 | 501 | 159 | 387 | 95 | 60 | 89 | 134 | −20 |
| Dividends paid | 0 | 137 | 327 | 435 | 388 | 242 | 52 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 146 | 8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 22 | 18 | 0 | 0 |
| Stock-based compensation | — | — | — | 0 | −0 | — | 0 | 17 | 39 | 17 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 3,035 | 2,862 | 2,327 | 1,782 | 1,553 | 1,422 | 899 | 1,450 | 722 | — |
| Debt incl. finance leases | — | — | — | — | — | — | — | — | — | — |
| Total assets | 4,239 | 4,738 | 3,867 | 3,441 | 3,081 | 3,242 | 3,090 | 4,051 | 4,151 | 1,528 |
| Total liabilities | 834 | 749 | 1,120 | 1,396 | 1,126 | 1,282 | 1,358 | 1,713 | 1,521 | 1,057 |
| Shareholders' equity | 3,287 | 3,877 | 2,633 | 1,931 | 1,834 | 1,838 | 1,623 | 2,071 | 2,546 | 478 |
| Margins and ratios | ||||||||||
| Gross margin | — | — | — | — | — | — | — | — | — | — |
| Operating margin | −0.2% | 6.7% | 12.3% | 12.7% | 9.2% | 9.2% | 6.1% | 6.4% | −33.6% | −7.0% |
| Net margin | 4.1% | 11.1% | 17.8% | 5.2% | 8.2% | 7.7% | 3.6% | 10.2% | 34.2% | −408.8% |
| Free cash flow margin | 1.9% | 3.2% | 14.4% | 4.3% | 11.8% | 2.9% | 2.2% | 3.2% | 10.1% | −3.5% |
| Rule of 40 (growth + FCF margin) | 67.9% | 3.4% | −0.7% | 11.0% | 0.0% | 3.0% | −12.8% | 2.5% | −41.7% | −61.7% |
| Return on capital | — | — | — | — | — | — | — | — | — | — |
| Return on equity | 5.1% | 12.6% | 19.0% | 8.4% | 14.2% | 13.7% | 5.8% | 15.2% | 19.7% | −150.4% |
| Return on assets | 4.1% | 10.1% | 14.3% | 5.3% | 8.2% | 7.9% | 3.2% | 7.9% | 11.1% | −80.1% |
| Net debt to EBITDA | — | — | — | — | — | — | — | — | — | — |